NewAmsterdam Pharma (NAMS) Exchange Rate Effect (2023 - 2026)

NewAmsterdam Pharma has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$1.3 million for Q1 2026.

• Exchange Rate Effect for Q1 2026 came in at -$1.3 million, down 135.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (up 1531.03% YoY), and the FY2025 annual result was $12.8 million, up 287.58% from the prior year.
• Exchange Rate Effect came in at -$1.3 million for Q1 2026 at NewAmsterdam Pharma, down from -$60000.0 in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $8.8 million in Q2 2025 to a low of -$7.9 million in Q4 2024.
• The 4-year median for Exchange Rate Effect is -$9668.6 (2023), against an average of $869025.5.
• Across the five-year window, Exchange Rate Effect sank 9301.61% in 2024 and soared 1070.96% in 2025, its largest moves.
• NewAmsterdam Pharma's Exchange Rate Effect stood at $5.2 million in 2023, then sank by 252.05% to -$7.9 million in 2024, then jumped by 99.24% to -$60000.0 in 2025, then sank by 2120.0% to -$1.3 million in 2026.
• The last three Exchange Rate Effect figures came in at -$1.3 million (Q1 2026), -$60000.0 (Q4 2025), and $222000.0 (Q3 2025), per Business Quant data.